clovoxamine

Clovoxamine is a synthetic antidepressant that belongs to the class of selective serotonin reuptake inhibitors (SSRIs). It was developed in the 1970s and is structurally related to fluvoxamine, but it is a distinct compound. Clovoxamine acts primarily by inhibiting the reuptake of serotonin in the brain, thereby increasing serotonin levels and exerting antidepressant effects. Unlike fluvoxamine, clovoxamine has not been widely marketed or approved for clinical use in major pharmaceutical markets such as the United States or Europe. Its primary indication was investigated for depression and anxiety disorders, but it did not reach widespread clinical adoption.

Brand names

clovoxamine

Other names

clovoxamine